← All trials
NCT04687800
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 4, 2021
- Primary completion
- Jan 31, 2021
- Completion date
- Apr 1, 2021
- First posted
- Dec 29, 2020
- Last posted
- Dec 31, 2020
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Eye AssociatesLead sponsor
- Ocular Therapeutix, Inc.Collaborator
- The Eye Associates of ManateeOverall official - principal investigator
- The Eye AssociatesSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.